Financial transparency with regard to payments and other transfers of value to healthcare Practitioners participating in clinical trials has been the subject of intense debate over recent months. Samuel Whitaker of Greenphire explains why transparency reporting requirements in other countries, demonstrates the urgency for adopting more efficient methods of managing payments and providing transparency across trials and across geopolitical boundaries.
 
http://jforcs.com/jcs/wp-content/uploads/2013/06/12.-Pay-it-Forward-Regulatory-Compliance-e-payment-Strategies-for-Patient-Physician-Reimbursement-in-Clinical-Trials.pdf